Related references
Note: Only part of the references are listed.MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Nelly Burnichon et al.
CLINICAL CANCER RESEARCH (2012)
The genetics of phaeochromocytoma: using clinical features to guide genetic testing
Mariam Jafri et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
HIF2AMutations in Paraganglioma with Polycythemia
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhengping Zhuang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2011)
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Yaoting Gui et al.
NATURE GENETICS (2011)
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Yuejuan Qin et al.
NATURE GENETICS (2010)
HIF-2α deletion promotes Kras-driven lung tumor development
Jolly Mazumdar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis
Deepak Rai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes
Guoliang Qing et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
Alexander Pietras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Whole-genome sequencing and variant discovery in C-elegans
LaDeana W. Hillier et al.
NATURE METHODS (2008)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
The hypoxia-inducible factor 2α N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo
Qin Yan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis
MJ Percy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
S Lee et al.
CANCER CELL (2005)
Genetic evidence for a tumor suppressor role of HIF-2α
T Acker et al.
CANCER CELL (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Structure of an HIF-1α-pVHL complex:: Hydroxyproline recognition in signaling
JH Min et al.
SCIENCE (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway
AP Gimenez-Roqueplo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
